Summit Therapeutics Inc. Common Stock

SMMT XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

11B

Short interest (Jul 15)

4.8%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.38%

↓ 6.8%

Available Shares

10M

↓ 0.0%

Price Chart

Company Overview

Summit Therapeutics Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel antibiotics for serious infectious diseases. Its CDI (Clostridiodes difficile infection) product candidate is ridinilazole, an orally administered small molecule antibiotic. It has two geographical segments: the United States and the United Kingdom.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001599298

Asset Type: CS

Market Data

Market Cap: $10,897,259,563

Employees: 265

Status: Active

Short Interest

Current Borrow Fee 0.38%

Range: 0.38% - 0.40%

Available Shares 10M

Range: 10M - 10M

Recent Changes

Fee Change: ↓ 2.2%

Available Change: ↓ 0.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime